Allotment

Neochem Bio IPO is a book-built issue with an open date of December 2, 2025, and a closing date of December 4, 2025. The company aims to raise approximately ₹44.97 crore through the IPO, comprising a fresh issue of equity shares with a face value of ₹10 each.
The price band for the IPO is ₹93 to ₹98 per share. The allocation is structured as 35% for retail investors, 50% for Qualified Institutional Buyers (QIBs), and 15% for High Net-worth Individuals (HNIs). The allotment date is December 5, 2025, and the shares are proposed to be listed on NSE on December 9, 2025.
Financial Highlights
Revenue: ₹86.15 crore in FY2025, up from ₹62.01 crore in FY2024
Profit: ₹7.75 crore in FY2025, up from ₹1.80 crore in FY2024
Based on the financial performance, Neochem Bio IPO is recommended for long-term investors.
₹980%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 9 Dec |
| IPO Listing Date | 9 Dec |
| IPO Face Value | ₹10 per share |
| IPO Price Range | ₹98.00 |
| IPO Issue Size | 45,88,800 shares |
| IPO Sale Type | Fresh Capital |
| Employee Discount | - |
| IPO Issue Type | Bookbuilding IPO |
| IPO Listing | NSE SME Platform |
| Share Holding Pre Issue | 1,25,31,953 shares |
| IPO Open Date | 2 Dec |
| IPO Close Date | 4 Dec |
| IPO Allotment (Tentative) | 6 Dec |
| Refunds | 8 Dec |
| Credit to Demat Account | 8 Dec |
| IPO Listing Date | 9 Dec |
| Category | Offer |
|---|---|
| QIB Shares Offered | 21,74,400 |
| NII (HNI) Shares Offered | 6,55,200 |
| Retail Shares Offered | 15,26,400 |
Investors can bid for a minimum of 2,400 shares, and any additional shares must be in multiples of 1,200.
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹2,35,200 |
| Retail (Max) | 2 | 2,400 | ₹2,35,200 |
| S-HNI (Min) | 3 | 3,600 | ₹3,52,800 |
| S-HNI (Max) | 8 | 9,600 | ₹9,40,800 |
| B-HNI (Min) | 9 | 10,800 | ₹10,58,400 |
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the manufacturing of specialty performance chemicals.
The company’s products are widely used across industries such as textile and garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber, and dyes & pigments.
Neochem Bio offers a comprehensive range of textile and garment washing auxiliaries, covering pre-treatment, dyeing, finishing, printing, and coating applications across all fabric and garment substrates, compatible with various processing machines.
The company’s manufacturing facility is located at Saket Industrial Estate, Village Moraiya, Ta. Sanand, Dist-Ahmedabad, with an installed capacity of 22,000 metric tons per annum (MTPA) and a total area of 6,763 square meters.
Competitive Strengths :
Strong presence across diverse end-user industries
Commitment to continuous development of innovative and sustainable performance chemistries
Focus on expanding geographical reach
Leveraging strategic collaborations and partnerships to diversify end-user industries
| Assets | 96.49 | 78.89 | 64.06 |
| Total Income | 47.18 | 86.15 | 62.01 |
| Profit After Tax | 5.48 | 7.75 | 1.8 |
| EBITDA | 8.59 | 13.11 | 5.99 |
| NET Worth | 32.24 | 19.75 | 12 |
| Reserves and Surplus | 19.7 | 13.08 | 5.33 |
| Total Borrowing | 38.54 | 35.62 | 33.32 |
| ROE | 49% |
| ROCE | 42% |
| Debt/Equity | 1.8 |
| RoNW | 48.82% |
| PAT Margin | 9.00% |
| EBITDA Margin | 15.58% |
| Price to Book Value | 5.8 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | - |
| 2 | To meet out the expenses of Working Capital Requirement | 23.90 |
| 3 | To meet out the General Corporate Purposes; | 6.44 |
| 4 | Offer for Sale (OFS) | - |
Neochem Bio Solutions Ltd.
303,
W1, Opp. Vikramnagar Colony,
Off. Iscon- Ambli Road,
Ahmedabad, Gujarat, 380058
Phone: +91 079 35217792
Email: compliance@neochem.in
Website: http://www.neochem.in/
IPO Registrar
MUFG Intime India Pvt. Ltd.
Phone: +91-22-4918 6270
Email: neochem.smeipo@in.mpms.mufg.com
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Neochem Bio IPO was a book-built issue open from December 2 to December 4, 2025, raising approximately ₹44.97 crore through a fresh issue of equity shares.
The IPO price band was ₹93–₹98 per share. Retail investors could apply for a minimum of 2,400 shares, requiring an investment of ₹2,35,200 at the upper price band.
Neochem Bio shares are proposed to be listed on NSE SME. Allotment was finalized on December 6, 2025, with shares credited to Demat accounts on December 8, 2025, and listing on December 9, 2025.
Funds will be used for long-term working capital requirements (₹23.90 crore), repayment/prepayment of borrowings (₹10 crore), and general corporate purposes (₹6.44 crore).
For FY2025, Neochem Bio reported ₹86.15 crore revenue, up from ₹62.01 crore, and ₹7.75 crore PAT, up from ₹1.80 crore. EBITDA margin stood at 15.58% with ROE at 49%.